Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2233 (LINC02233)

Target
LINC02233
Molecular classification
Long non-coding RNA, lincRNA
01

Overview

Long intergenic non-protein coding RNA 2233 (LINC02233) is a long non-coding RNA (lncRNA), specifically classified as a long intergenic non-coding RNA (lincRNA), meaning it is transcribed from regions of the genome outside of protein-coding genes[1][3][5][9]. LINC02233 does not encode a protein but may participate in transcriptional or post-transcriptional regulatory processes, consistent with other lincRNAs, which can regulate gene expression, influence chromatin states, and modulate cellular functions[11]. Its HGNC ID is 53104 and it is also known by the alias RP11-6C14.1[1][3][9]. LINC02233 is located at chromosome 4q32[5]. There is currently no evidence confirming LINC02233 as a conventional therapeutic target such as a receptor, enzyme, transporter, or direct participant in established drug mechanisms, nor are there any known drugs that specifically target this lincRNA. Many lincRNAs are under investigation for their biological roles in diseases, including cancer, but no direct biological functions or disease associations (as a biomarker or target) have been firmly established for LINC02233 to date[9][11].

Other names
RP11-6C14.1
02

Biological functions

Gene regulationnon-coding RNA functionspecific functions of LINC02233 largely unknown
03

Disease associations

Some lincRNAs are implicated in cancer and other diseases in general, but no direct disease association established for LINC02233 specifically

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2233 (LINC02233).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2233 (LINC02233).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call